Overview

Update
Total Equity Funding
$5.48M in 1 Round from 2 Investors
Most Recent Funding
$5.48M Series A on May 16, 2012
Headquarters:
Erkrath
Description:
Algiax Pharmaceuticals develops products for nervous system disease or dysfunction with a strong focus on neuropathic pain.
Founders:
,
Categories:
Biotechnology
Website:
http://www.algiax.com

Company Details

Update
Founded:
2011
Contact:
49 211 617 851 0
Employees:
1 - 10 | 4 in Crunchbase

Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro’s in Series A financing from a consortium of private and state-backed investors.

Funding Rounds (1) - $5.48M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2012€4.3M / Series A2

Investors (2)

InvestorRound(s)Partner(s)
Series A (Lead)-
Series A (Lead)-

Current Team (4)

Update

News (1)

Update
DateNews
May 16, 2012FinSMEs - FinSMEs

Offices/Locations (1)

Update
  • Office

    Max-Planck-Str. 15a

    Erkrath, 40699

    DEU

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos